Virica Biotech and Ginkgo Bioworks Announce Partnership to Accelerate AAV Gene Therapy Manufacturing [Yahoo! Finance]
Ginkgo Bioworks Holdings, Inc. (DNA)
Company Research
Source: Yahoo! Finance
Ginkgo Bioworks will leverage their advanced screening platform for rapid testing of VSEs directly in clients' cell lines. BOSTON & OTTAWA, Ontario, October 03, 2024 BUSINESS WIRE )--Ginkgo Bioworks, Inc. ("Ginkgo") which is building the leading platform for cell programming and biosecurity, and Virica Biotech Inc. ("Virica"), a leading developer of enhancers for scaling of viral vectors as well as cell and gene therapies, today announced a strategic partnership to enhance each company's adeno-associated virus (AAV) gene therapy manufacturing platforms. This collaboration aims to tackle one of the major barriers to the widespread adoption of AAV-based gene therapies: the high cost of manufacturing. A combined offering will leverage the advanced capabilities of Ginkgo's AAV Services for Gene Therapy and Virica's proprietary VSE™ enhancer platform to offer innovators services and products to enhance AAV production titers and quality to reduce production costs and make gene therapie
Show less
Read more
Impact Snapshot
Event Time:
DNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNA alerts
High impacting Ginkgo Bioworks Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
DNA
News
- Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade [Yahoo! Finance]Yahoo! Finance
- NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal AgriculturePR Newswire
- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) had its price target raised by analysts at TD Cowen from $3.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- Pomerantz LLP Announces that this is a Reminder of a Proposed Class Action Settlement on Behalf of Purchasers of Ginkgo Bioworks Holdings, Inc. Common Stock - DNAGlobeNewswire
- Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology [Yahoo! Finance]Yahoo! Finance
DNA
Earnings
- 8/8/24 - Miss
DNA
Sec Filings
- 10/4/24 - Form 144
- 10/4/24 - Form 144
- 10/3/24 - Form 144
- DNA's page on the SEC website